FDA’s Draft Guidance on Laboratory-Developed Tests Increases Clinical and Economic Risk to Adoption of Pharmacogenetic Testing

Simple item page
dc.contributor.authorLevy, Kenneth D.
dc.contributor.authorPratt, Victoria M.
dc.contributor.authorSkaar, Todd C.
dc.contributor.authorVance, Gail H.
dc.contributor.authorFlockhart, David A.
dc.contributor.departmentDepartment of Medicine, IU School of Medicineen_US
dc.date.accessioned2016-02-12T14:14:58Z
dc.date.available2016-02-12T14:14:58Z
dc.date.issued2015-07
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationLevy, K. D., Pratt, V. M., Skaar, T. C., Vance, G. H., & Flockhart, D. A. (2015). FDA's Draft Guidance on Laboratory-Developed Tests Increases Clinical and Economic Risk to Adoption of Pharmacogenetic Testing. Journal of clinical pharmacology, 55(7), 725.en_US
dc.identifier.urihttps://hdl.handle.net/1805/8303
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/jcph.492en_US
dc.relation.journalThe Journal of Clinical Pharmacologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectUS Food and Drug Administrationen_US
dc.subjectlaboratory-developed testsen_US
dc.subjectpharmacogenetic testingen_US
dc.titleFDA’s Draft Guidance on Laboratory-Developed Tests Increases Clinical and Economic Risk to Adoption of Pharmacogenetic Testingen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Levy2015-FDAdraftguidance.pdf
Size:
295.5 KB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
nihms750590.pdf
Size:
120.86 KB
Format:
Adobe Portable Document Format
Description:
NIH PA Manuscript
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works
Todd Skaar